C4 Therapeutics Inc
NASDAQ:CCCC
C4 Therapeutics Inc
NASDAQ:CCCC
Price:
3.17
USD
7.46%
Market Closed
Market Cap:
$309.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
S
|
Stadio Holdings Ltd
JSE:SDO
|
ZA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
CA |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
NN Group NV
AEX:NN
|
NL |
|
Acushnet Holdings Corp
NYSE:GOLF
|
US |
|
Papa John's International Inc
NASDAQ:PZZA
|
US |
|
Morgan Stanley
NYSE:MS
|
US |
|
T
|
Thanapiriya PCL
SET:TNP
|
TH |
|
Nutrien Ltd
TSX:NTR
|
CA |
|
Housing Development Finance Corporation Ltd
NSE:HDFC
|
IN |
|
F5 Inc
NASDAQ:FFIV
|
US |
Wall St Price Targets
CCCC Price Targets Summary
C4 Therapeutics Inc
C4 Therapeutics Inc
Wall Street analysts forecast CCCC stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CCCC is 11.8 USD with a low forecast of 6.06 USD and a high forecast of 31.5 USD.
Lowest Forecast
Price Target
6.06
USD
91% Upside
Average Forecast
Price Target
11.8
USD
272% Upside
Highest Forecast
Price Target
31.5
USD
894% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CCCC's stock price target?
Price Target
11.8
USD
11.8
USD
According to Wall Street analysts, the average 1-year price target for CCCC is 11.8 USD with a low forecast of 6.06 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for C4 Therapeutics Inc?
Projected CAGR
46%
46%
Over the last 6 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 46%.
